Instil Bio Inc. (NASDAQ:TIL) — Market Cap & Net Worth
Market Cap & Net Worth: Instil Bio Inc. (TIL)
Instil Bio Inc. (NASDAQ:TIL) has a market capitalization of $48.90 Million ($48.90 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22062 globally and #4915 in its home market, demonstrating a -4.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Instil Bio Inc.'s stock price $7.21 by its total outstanding shares 6781976 (6.78 Million). Also see total assets of Instil Bio Inc. for a full breakdown of the balance sheet.
Instil Bio Inc. Market Cap History: 2021 to 2026
Instil Bio Inc.'s market capitalization history from 2021 to 2026. Data shows change from $2.32 Billion to $48.90 Million (-54.19% CAGR). Also see cash efficiency ratio of Instil Bio Inc. for how efficiently the company converts equity into cash flow.
Index Memberships
Instil Bio Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #635 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #2101 of 3165 |
Weight: Instil Bio Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Instil Bio Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Instil Bio Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Instil Bio Inc. (TIL) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TIL by Market Capitalization
Companies near Instil Bio Inc. in the global market cap rankings as of September 18, 2026. Review TIL intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Instil Bio Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Instil Bio Inc. Historical Marketcap From 2021 to 2026
Between 2021 and today, Instil Bio Inc.'s market cap moved from $2.32 Billion to $ 48.90 Million, with a yearly change of -54.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $48.90 Million | -34.45% |
| 2025 | $74.60 Million | -42.38% |
| 2024 | $129.47 Million | +150.52% |
| 2023 | $51.68 Million | -39.52% |
| 2022 | $85.45 Million | -96.32% |
| 2021 | $2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Instil Bio Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $48.90 Million USD |
| MoneyControl | $48.90 Million USD |
| MarketWatch | $48.90 Million USD |
| marketcap.company | $48.90 Million USD |
| Reuters | $48.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Instil Bio Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.